Medication‐Related Admissions Among Older Patients in a Danish Emergency Department: Prevalence, Preventability and Characterisation
Abstract
The prevalence of medication‐related admissions (MRAs) among older medical patients admitted to Danish emergency departments (EDs) remains limited. We aimed to determine the prevalence of possibly medication‐related admissions (PMRAs) in this population, assess their preventability and identify patient characteristics that distinguish between patients with and without a PMRA. This retrospective, exploratory, descriptive secondary analysis included acutely admitted older medical patients (≥ 65 years) from the ED of Copenhagen University Hospital Hvidovre, Denmark, between October 2018 and April 2021. PMRAs were initially assessed using the Assessment Tool for Hospital Admissions Related to Medications, followed by final classifications and preventability assessments by an experienced panel of pharmacists and a pharmacologist. Among 193 admissions, 31 (16.1%) were classified as PMRAs, and 15 (48.4%) and 11 (35.5%) of these were deemed potentially or definitely preventable, respectively. Untreated conditions (19.4%) and miscommunication (16.1%) were identified as the most common reasons for PMRAs. No specific patient characteristics reliably distinguished between patients with and without a PMRA. In conclusion, MRAs appear to be highly prevalent in Danish EDs, emphasising the need for improved identification and prevention strategies.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.